Tip to assist your neoantigen design

Neoantigens are stated as the antigens that have not been previously recognized by the immune system. Typically, neoantigens are encoded by tumor-specific mutated genes and have been recognized as new approach to cope with cancer. Besides of specificity, the turnaround time to produce enoantigen peptide candidates is crucial. Based on this, a tool is designed and developed to help investigators to evaluate the difficulty of peptide synthesis to guide their neoantigen sequence design. Please check GenScript Peptide Assistied Design Tool at https://www.genscript.com/tools/neoantigen-peptide.